EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway

Jing Wang iD, Zheng Huang, Zhiyong Cao, Yehao Luo, Yueting Liu, Huilu Cao, Xiusong Tang, Gang Fang

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252011146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jing Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Key Laboratory for Applied Fundamental Research of Zhuang Medicine-Key Laboratory Project under Guangxi Health Commission, Guangxi University…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance, Signal Transduction, Disease Models, Animal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key TCM Disciplines/Medicine for ETHNIC Minorities (Zhuang Medicine), Guangxi Multidisciplinary Innovation Grant in Traditional Chinese Medicine, Guangxi Health Commission Key Laboratory of Applied Fundamental Research of Zhuang Medicine (Guangxi University of Chinese Medicine).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary yndrome (PCOS) is a common metabolic disorder in women, which is usually associated with insulin resistance (IR) and chronic inflammation. Loureirin B (LrB) can effectively improve insulin resistance and alleviate chronic inflammation, and in order to investigate the therapeutic effect of LrB on polycystic ovary syndrome with insulin resistance (PCOS-IR), we conducted animal experiments. A PCOS-IR rat model was established by feeding a high-fat diet combined with letrozole (1 mg/kg·d for 21 days). The rats were treated with the GPR120 agonists TUG-891 and LrB for 4 weeks. Biochemical parameters (fasting blood glucose, total cholesterol, triglycerides, high- and low-density lipoprotein), hormone levels (serum insulin, E2, T, LH, and FSH), and inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-18) were analyzed. Histopathological analyses of ovaries were performed using hematoxylin/eosin (H&E) staining. Real-time PCR and western blotting were used to assess GPR120, NLRP3, and caspase-1 expression in ovaries, and immunohistochemistry was used to evaluate LKB1 and AMPK protein expression. LrB reduced body weight, Lee’s index, ovarian index, ovarian area, and volume in PCOS-IR rats. It lowered fasting blood glucose, serum insulin, and HOMA-IR. LrB decreased total serum cholesterol, triglyceride, and LDL levels and increased HDL levels. It reduced serum T, LH, and LH/FSH and raised serum E2 and FSH levels. LrB downregulated the mRNA and protein expression levels of NLRP3 and Caspase-1, increased the protein and mRNA expression levels of GPR120 in rat ovaries, and increased LKB1 and AMPK protein expression in ovaries, ameliorating ovarian histopathological changes in PCOS-IR rats. Taken together, LrB upregulated GPR120, LKB1, and AMPK protein expression, downregulated NLRP3 and Caspase-1 protein expression, reduced insulin resistance and chronic inflammation, and ameliorated histopathological changes in ovarian tissues in PCOS rats, suggesting its potential as a treatment for PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInsulin ResistanceSignal TransductionDisease Models, AnimalAMP-Activated Protein KinasesInflammationReceptors, G-Protein-CoupledAnimalsFemaleRatsProtein Serine-Threonine KinasesRats, Sprague-DawleyAMP-Activated Protein Kinase KinasesUp-Regulation

Stichwörter der Autor:innen

GPR120LKB1/AMPK signaling pathwayinflammationinsulin resistanceloureirin Bpolycystic ovary syndrome

Substanzen

AMP-Activated Protein KinasesReceptors, G-Protein-CoupledStk11 protein, ratProtein Serine-Threonine KinasesAMP-Activated Protein Kinase Kinases

Autor:innen und Institutionen

  • Guangxi Key Laboratory for Applied Fundamental Research of Zhuang Medicine-Key Laboratory Project under Guangxi Health Commission, Guangxi University of Chinese Medicine, Nanning 530001, China.
  • Guangxi Higher Education Key Laboratory for the Research of Du-Related Diseases in Zhuang Medicine, Guangxi University of Chinese Medicine, Nanning 530001, China.
  • Health Science Center, Hubei Minzu University, Enshi 445000, China.
  • The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China.

ORCID-Profile: Jing Wang

Förderung

  • Key TCM Disciplines/Medicine for ETHNIC Minorities (Zhuang Medicine)
  • Guangxi Multidisciplinary Innovation Grant in Traditional Chinese Medicine
  • Guangxi Health Commission Key Laboratory of Applied Fundamental Research of Zhuang Medicine (Guangxi University of Chinese Medicine)
  • Training Program under the “139” Plan for Developing High-level Medical Talent in Guangxi
  • Guangxi Higher Education Key Laboratory for the Research of Du-related Diseases in Zhuang Medicine

Zitieren

APA

Wang, J., Huang, Z., Cao, Z., Luo, Y., Liu, Y., Cao, H., Tang, X., & Fang, G. (2024). Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011146

Vancouver

Wang J, Huang Z, Cao Z, Luo Y, Liu Y, Cao H, et al. Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011146

BibTeX
@article{Wang2024,
  author = {Wang, Jing and Huang, Zheng and Cao, Zhiyong and Luo, Yehao and Liu, Yueting and Cao, Huilu and Tang, Xiusong and Fang, Gang},
  title = {Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252011146}
}
Kostenlos starten →